| 发明名称 |
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |
| 摘要 |
<p>The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.</p> |
| 申请公布号 |
CA2874032(A1) |
申请公布日期 |
2013.11.28 |
| 申请号 |
CA20132874032 |
申请日期 |
2013.05.21 |
| 申请人 |
GANYMED PHARMACEUTICALS AG;TRON - TRANSLATIONALE ONKOLOGIE AN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH |
发明人 |
SAHIN, UGUR;TURECI, OZLEM;MITNACHT-KRAUS, RITA;JACOBS, STEFAN DENIS;UTSCH, MAGDALENA JADWIGA;HEINZ, CORNELIA ADRIANA MARIA;STADLER, CHRISTIANE REGINA |
| 分类号 |
A61K39/395;A61K45/06;C07K16/30 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
